Vaccine, Vol. 32, Issue 14, pp. 1523-1640 (20 March 2014)
The confluence of global efforts related to sexual and reproductive health and advancement of vaccines offers a critical new opportunity for STI prevention, and a call to action. The success stories of hepatitis B and HPV vaccine development and uptake can inspire and catalyze development of new vaccines against additional STIs. Sexual and reproductive health and vaccine development are both high on the global health agenda. Now is the time to capitalize on these global efforts and accelerate progress toward new STI vaccines.